Qualitek Labs Ltd

Qualitek Labs Limited will hold a board meeting on November 13, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the half year ended September 30, 2026, and a proposal for alteration of the company’s Memorandum of Association, according to a regulatory filing. The company also announced that the trading window for its securities has been closed from October 1, 2026, and will remain so until 48 hours after the financial results are declared.

Qualitek Labs Limited informed the BSE Limited that Ajay Agarwal has resigned as a Non-Executive Independent Director of the company, effective October 29, 2026, due to personal reasons. Mr. Agarwal, who held Director Identification Number 06778079, was not a member of any board committee and does not hold directorships in any other listed entities.

Qualitek Labs Limited informed the BSE Limited that Ajay Agarwal has resigned as a Non-Executive Independent Director of the company, effective October 29, 2026, due to personal reasons. Mr. Agarwal, who held Director Identification Number 06778079, was not a member of any board committee and does not hold directorships in any other listed entities.

Qualitek Labs Ltd. is down 5.00% to Rs 525.35, extending recent declines and falling 7.74% over the last week. Qualitek Labs Limited announced that its wholly owned subsidiary, Interstellar Testing Centre Private Limited, has received a work order from the Bio-Resources Development Centre (BRDC), Government of Meghalaya, for services related to the setup, operation, and accreditation of a Quality Control and Analytical Laboratory. The work order, considered to be in the normal course of business, does not disclose the consideration or execution timeline due to commercial confidentiality, and does not involve any related party transactions. Trading volume reached 6800 shares today, a decrease of 29.17% from the one-week average. Qualitek Labs Ltd expanded by 22.17% year-over-year, outperforming the 9.53% loss in the NIFTY50 index.

Qualitek Labs Limited informed the Bombay Stock Exchange that its trading window for dealing in securities will be closed from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ended September 30, 2026, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct.

Qualitek Labs Limited announced that its Preferential Issue Committee approved the substitution of Vibha Singhi, who was to receive 16,000 equity shares, with Jagattaraini Tieup Private Limited, which will now receive 16,000 equity shares, subject to regulatory and shareholder approvals.

Qualitek Labs Limited’s board approved a preferential issue of up to 386,000 equity shares at Rs 518.55 per share, aggregating up to Rs 20.02 crore, and a preferential issue of up to 520,000 fully convertible warrants at Rs 518.55 per warrant, aggregating up to Rs 26.96 crore, to proposed allottees listed in annexures A1 and B1, respectively. The company also decided to call an Extraordinary General Meeting on October 16, 2026, and approved the draft notice for the meeting.

Qualitek Labs Limited will seek board approval for a fundraising exercise on September 22, 2026, which may include the issuance of equity shares or other equity-linked instruments via a rights issue, preferential allotment, or private placement, among other methods, according to a regulatory filing with the BSE Limited on September 17, 2026. The company’s trading window will be closed for directors, promoters, and designated persons from September 17, 2026, until September 24, 2026.

Qualitek Labs Limited’s board of directors approved the draft notice for the company’s 8th Annual General Meeting (AGM) to be held on September 25, 2026, in New Delhi, and recommended the re-appointment of Mr. Antaryami Nayak as Managing Director and CEO, who retires by rotation. The board also approved the re-appointment of M/s J Madan & Associates as the company’s Tax Auditor for the financial year 2026–27 and proposed an increase in the overall managerial remuneration limits from 28% to 35% of net profits, subject to member approval at the AGM.

Qualitek Labs will hold a meeting of the Board of Directors of the Company on 15 May 2026.